We present a critical review of the state of the art of magnetic particle hyperthermia (MPH) as
a minimal invasive tumour therapy. Magnetic principles of heating mechanisms are …

Magnetic nanoparticle hyperthermia (MNH) is a promising nanotechnology-based cancer
thermal therapy that has been approved for clinical use, together with radiation therapy, for …

Purpose: We aimed to characterise magnetic nanoparticle hyperthermia (mNPH) with
radiation therapy (RT) for prostate cancer. Methods: Human prostate cancer subcutaneous …

The combined delivery of photo-and chemo-therapeutic agents is an emerging strategy to
overcome drug resistance in treating cancer, and controlled light-responsive drug release is …

Multifunctional nanoparticles integrating cancer cell imaging and treatment modalities into a
single platform are recognized as a promising approach; however, their development …

Magnetic nanoparticles dissipate heat when exposed to alternating magnetic fields (AMFs),
making them suitable for cancer hyperthermia. Therapeutic heating applications demand …

Magnetic nanoparticle-mediated hyperthermia (MNHT) generates heat to a local tumor
tissue of above 43° C without damaging surrounding normal tissues. By applying MNHT, a …

Cell-membrane hybrid nanoparticles (NPs) are designed to improve drug delivery, thermal
therapy, and immunotherapy for several diseases. Here, we report the development of …

We developed a magnetic solid lipid nanoparticles formulation of paclitaxel (PTX-loaded
MSLNs) via emulsification-diffusion method. The physicochemical characterization of PTX …

Non-invasive and real-time monitoring of the heat delivery during magnetic nanoparticle
hyperthermia (MNH) is of fundamental importance to predict clinical outcomes for cancer …